Venus Remedies

Venus Remedies has secured new marketing authorizations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam. These regulatory…

The 132,000 sq ft VGFC aims to improve logistics, regulatory compliance, and timely access to medicines across over 100 countries

Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre highlights how…

Extending its reach directly to pharmacies and small retailers, Venus Remedies now operates a parallel online delivery system

The certification applies to the company's Unit-II manufacturing facility located in Baddi, Himachal Pradesh, covering its…

As a UNGC participant, the company will publish an annual CoP to share updates on its sustainability performance and adherence to…

The QIDP designation provides regulatory benefits, advancing efforts to combat antimicrobial resistance

Venus Remedies will test APC-148 in combination with various antibiotics against its extensive library of clinical isolates…

The global Sugammadex market, valued at approximately 1.53 billion in 2023, is projected to grow at a CAGR of 8.5 per cent,…

On an exclusive licensing agreement, Venus Remedies will lead clinical trials and commercialisation of MET-X to combat…